Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact firstname.lastname@example.org.
Foghorn® Therapeutics Appoints Carl P. Decicco, Ph.D. as Chief Scientific Officer
Flagship Pioneering Names Ryan Watts, CEO of Denali Therapeutics, as Recipient of the 2018 Pioneering Leader Award
Flagship Pioneering Launches Foghorn Therapeutics With Initial Capital Commitment of $50 Million